Abstract:You have accessJournal of UrologyBladder Cancer: Basic Research IV1 Apr 2014MP39-13 RESVERATROL SENSITIZES BLADDER CANCER CELLS TO TRAIL-INDUCED APOPTOSIS Dong Zhang, Xiaojie Yang, Hongliang Li, and Tie Chong Dong ZhangDong Zhang More articles by this author , Xiaojie YangXiaojie Yang More articles by this author , Hongliang LiHongliang Li More articles by this author , and Tie ChongTie Chong More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.1328AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Resveratrol (3,4′,5 tri-hydroxystilbene) is a phytoalexin that is found in the skin of grapes. Several studies showed that resveratrol possesses anti-inflammatory, anti-oxidant, and anti-cancer properties. Here, we investigated the potential role of resveratrol and its interactive effects with TRAIL on apoptosis in bladder cancer cells and its possible mechanisms. METHODS MTT was used to detect effects of resveratrol or/and TRAIL on cell growth in 5637 and T24 cells. Apoptosis and mitochondrial transmembrane potential (δψm) were determined by flow cytometry after treatment of resveratrol or/and TRAIL. Death receptor (DR) 4, DR 5, and apoptosis associated proteins were detected using Western blot. Effects of resveratrol alone or combination with TRAIL on growth of xenografts in nude mice were observed. RESULTS Resveratrol inhibited cell viability in a dose- and time-dependent manner. TRAIL failed to inhibit cell viability in 5637 and T24 cells, whereas cell proliferation was repressed in the presence of resveratrol. Resveratrol alone was able to induce apoptosis in both cells, whereas TRAIL was failed to induce apoptosis. Notably, combination of resveratrol and TRAIL resulted in significant apoptosis in RCC cells, and showed more effective in inducing apoptosis. Furthermore, a significant loss of δψm was obtained in resveratrol alone and combination of resveratrol and TRAIL treated cells compared to control cells, and TRAIL alone failed to trigger δψm collapse. Resveratrol alone or combination with TRAIL inhibited growth of 5637 xenografts in nude mice, and the combination of resveratrol and TRAIL was more effective in inhibiting tumor growth, however, TRAIL alone failed to repress tumor growth. Mechanistically, resveratrol upregulated the expression DR4 and DR5, and downregulated the expression of Bcl-2, Bcl-XL, and survivin. CONCLUSIONS Our data suggests that resveratrol inhibits bladder cancer 5637 and T24 cells proliferation in a time- and dose-dependent manner and induces cellular apoptosis. In addition, resveratrol could sensitize bladder cancer cells to TRAIL-induced apoptosis. The capability of resveratrol to inhibit tumor growth and enhance the therapeutic potential of TRAIL suggests that resveratrol alone or in combination with TRAIL can be used for the management of bladder cancer. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e430-e431 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Dong Zhang More articles by this author Xiaojie Yang More articles by this author Hongliang Li More articles by this author Tie Chong More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Mp88-16 targeted exosome-mediated delivery of survivin sirna for the treatment of bladder cancer

Study of Construction of Sirna Eukaryotic Expression Vector of Survivin Gene and Its Inhibitory Effect on Survivin Expression in Bladder Cancer Cells

siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers

Tumor-specific Delivery of KRAS Sirna with Irgd-Exosomes Efficiently Inhibits Tumor Growth

Targeted-delivery of Sirna Via a Polypeptide-Modified Liposome for the Treatment of Gp96 Over-Expressed Breast Cancer.

Abstract 1376: Engineered exosomes for the delivery of PD-L1 siRNA for lung cancer immunotherapy

Highly Stable Polyglutamate Derivatives/sirna Polyplex Efficiently Down-Relegate Survivin Expression and Augment the Efficacy of Cisplatin.

Mir-138-5p Contributes to Cell Proliferation and Invasion by Targeting Survivin in Bladder Cancer Cells

Silencing of Survivin Expression Leads to Reduced Proliferation and Cell Cycle Arrest in Cancer Cells.

MP39-13 RESVERATROL SENSITIZES BLADDER CANCER CELLS TO TRAIL-INDUCED APOPTOSIS

Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo

Active Targeting Co-Delivery of Therapeutic Sur Sirna and Antineoplastic Drug Via Epidermal Growth Factor Receptor Mediated Magnetic Nanoparticles for Synergistic Programmed Cell Death in Glioblastoma Stem Cells

Systemic Delivery Of Therapeutic Sirna By Multifunctional Mesoporous Silica-Based Nanocarrier Inhibits Lung Cancer Growth And Metastasis

Effect of RNAi-Mediated Survivin and Hypoxia-Inducible Factor 1α Gene Silencing on Proliferation, Invasion, Migration and Apoptosis of Gastric Cancer BGC-823 Cells

Additional File 3: Figure S3. of Mir-138-5p Contributes to Cell Proliferation and Invasion by Targeting Survivin in Bladder Cancer Cells

In Vitro Investigation of RGD-modified Stabilized Cationic Liposomes As Non-Viral Vehicle for Sirna Delivery

Tumor-suppressing Effect of Recombinant Adenovirus Encoding LRIG1 Gene Driven by Survivin Promoter in Nude Mice Heterotransplanted Models of Human Bladder Cancer

Integrin Receptor-Mediated Strategy for Tumor Targeting Delivery of siRNA and Doxorubicin

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma

Rna Interference-Mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell